ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
UH
Union Hospital (Tongji Medical College, HUST) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Union Hospital (Tongji Medical College, HUST) takes part in 10 sessions at ESMO 2026 in Madrid. Its work spans lung, gastrointestinal, genitourinary and gynaecological cancers, as well as rare cancers. Specific topics include treatment strategies for rectal cancer, bladder-preserving care and therapies for advanced cervical cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
UH Union Hospital (Tongji Medical College, HUST) Wuhan, China | |
Teaching hospital of Huazhong University of Science and Technology in Wuhan, China. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Development of diagnostic models and biomarker identification for type I leptomeningeal metastasis in lung denocarcinoma using olink: Exploratory cohort study Lung & thoracic cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Abstract Fri Oct 23 16:15–16:20 2394RO - Latest efficacy and safety analysis of surufatinib combined with EP regimen and serplulimab as first-line treatment for extrapulmonary neuroendocrine carcinoma Sarcoma, CNS, head & neck and rare cancers Poster Sat Oct 24 13:30–14:00 Abstract Sun Oct 25 11:10–11:20 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Adebrelimab plus bevacizumab and nab-paclitaxel in non-squamous NSCLC after progression on first-line ICI-based therapy: A phase II rechallenge study with biomarker analysis Lung & thoracic cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Union Hospital (Tongji Medical College, HUST)
Tell us what you sell and we’ll find the people at Union Hospital (Tongji Medical College, HUST) most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction